Fosaprepitant as combination therapy to prevent chemotherapy-induced vomiting in children: a meta-analysis
ObjectiveTo systematically evaluate the clinical efficacy and safety of fosaprepitant combined with 5-hydroxytryptamine 3 receptor antagonists (5-HT3RA) (with or without dexamethasone) on the chemotherapy-induced vomiting in pediatric cancer patients.MethodsPubMed, Embase, Cochrane Library, China Jo...
Saved in:
Main Authors: | Yanshuo Shi, Yuanyuan Yue, Yue Zhang, Guoxun Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1509928/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting
by: Lijuan He, et al.
Published: (2025-01-01) -
Comparison of efficacy and safety between palonosetron and ondansetron to prevent postoperative nausea and vomiting in patients undergoing non-laparoscopic surgery: A systematic review and meta-analysis of randomised controlled trials
by: Babu Lal, et al.
Published: (2025-01-01) -
Comparison of aprepitant versus ondansetron for prevention of postoperative nausea and vomiting: A systematic review and meta-analysis with trial sequential analysis
by: Madhusudan P. Singh, et al.
Published: (2024-09-01) -
Sustaining reductions in postoperative nausea and vomiting after evidence-based practice initiative: A success story
by: Christopher A Smith, et al.
Published: (2017-07-01) -
Effect of non-pharmacological interventions on chemotherapy induced delayed nausea and vomiting for tumors: A systematic review and Bayesian network meta-analysis
by: Yongni Wang, et al.
Published: (2025-03-01)